Cargando…

Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders

INTRODUCTION: To evaluate the usefulness of the 2018 NIA‐AA (National Institute on Aging and Alzheimer's Association) research framework in a longitudinal memory clinic study with different clinical outcomes and underlying disorders. METHODS: We included 420 patients with mild cognitive impairm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckerström, C., Svensson, J., Kettunen, P., Jonsson, M., Eckerström, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Diagnostic Assessment & Prognosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015813/ https://www.ncbi.nlm.nih.gov/pubmed/33816750 http://dx.doi.org/10.1002/dad2.12031

Ejemplares similares

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample
por: Eckerström, Marie, et al.
Publicado: (2017)

Better prognostic accuracy in younger mild cognitive impairment patients with more years of education
por: Göthlin, Mattias, et al.
Publicado: (2018)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020)

Evaluating combinations of diagnostic tests to discriminate different dementia types
por: Bruun, Marie, et al.
Publicado: (2018)

Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample
por: Jung, Youngsin, et al.
Publicado: (2017)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers
por: Goyal, Devendra, et al.
Publicado: (2018)

Identifying memory impairment and early dementia in primary care
por: Grober, Ellen, et al.
Publicado: (2017)

Subjective memory impairment: No suitable criteria for case-finding of dementia in primary care
por: Eichler, Tilly, et al.
Publicado: (2015)

Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment
por: Qiu, Shangran, et al.
Publicado: (2018)

Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies
por: Albanese, Emiliano, et al.
Publicado: (2017)

Prediction of poor clinical outcome in vascular cognitive impairment: TRACE‐VCI study
por: Boomsma, Jooske M.F., et al.
Publicado: (2020)

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021)

Function and clinical meaningfulness of treatments for mild Alzheimer's disease
por: Siemers, Eric, et al.
Publicado: (2016)

Carers' diaries in dementia: Is there a role in clinical practice?
por: Jayalath, Dilini, et al.
Publicado: (2016)

Revolutionizing Alzheimer's disease and clinical trials through biomarkers
por: Mattsson, Niklas, et al.
Publicado: (2015)

Assessing quality of life in Alzheimer's disease: Implications for clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2016)

Prevalence and clinical correlates of dementia among COVID‐19‐related deaths in Italy
por: Canevelli, Marco, et al.
Publicado: (2020)

Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
por: Galvin, James E.
Publicado: (2015)

Predicting time to dementia using a quantitative template of disease progression
por: Bilgel, Murat, et al.
Publicado: (2019)

Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis
por: Hughes, Timothy M., et al.
Publicado: (2017)

Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire
por: Jutten, Roos J., et al.
Publicado: (2017)

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
por: de Wilde, Arno, et al.
Publicado: (2017)

The incidence of mild cognitive impairment: A systematic review and data synthesis
por: Gillis, Cai, et al.
Publicado: (2019)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Development and internal validation of a predictive model of cognitive decline 36 months following elective surgery
por: Jones, Richard N., et al.
Publicado: (2021)

Women's higher brain metabolic rate compensates for early Alzheimer's pathology
por: Sundermann, Erin E., et al.
Publicado: (2020)

Alzheimer's disease severity, objectively determined and measured
por: Gross, Alden L., et al.
Publicado: (2016)

Development and validation of a salivary tau biomarker in Alzheimer's disease
por: Pekeles, Heather, et al.
Publicado: (2018)

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
por: Johnson, Sterling C., et al.
Publicado: (2017)

Normative data for the Brief Spanish‐English Verbal Learning Test for representative and diverse Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
por: Breton, Jordana, et al.
Publicado: (2021)

Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia
por: Wilson, Robert S., et al.
Publicado: (2021)

Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
por: Maserejian, Nancy, et al.
Publicado: (2019)

Clinician-patient communication during the diagnostic workup: The ABIDE project
por: Visser, Leonie N.C., et al.
Publicado: (2019)

Dual sensory impairment in older adults and risk of dementia from the GEM Study
por: Hwang, Phillip H., et al.
Publicado: (2020)

Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE study
por: King, Kevin S., et al.
Publicado: (2022)

Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2016)

The Role of Inflammation after Surgery for Elders (RISE) study: Study design, procedures, and cohort profile
por: Hshieh, Tammy T., et al.
Publicado: (2019)

Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
por: Jutkowitz, Eric, et al.
Publicado: (2020)

Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
por: Knopman, David S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ondouhakek57i8r7qn0h4d7ph0